{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:26:38Z","timestamp":1786998398748,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ygyno.2010.08.019","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T04:27:29Z","timestamp":1284784049000},"page":"594-600","source":"Crossref","is-referenced-by-count":86,"title":["Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model"],"prefix":"10.1016","volume":"119","author":[{"given":"K.","family":"Van Calsteren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Verbesselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Devlieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"De Catte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Van Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Heyns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.08.019_bb0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","article-title":"Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes","volume":"28","author":"Van Calsteren","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PPO.0b013e3181ce46f9","article-title":"Breast cancer during pregnancy: maternal and fetal outcomes","volume":"16","author":"Cardonick","year":"2010","journal-title":"Cancer J"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1040-8428(94)90043-4","article-title":"Pharmacology of antineoplastic agents in pregnancy","volume":"16","author":"Wiebe","year":"1994","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ctrv.2008.01.002","article-title":"Cancer in pregnancy: gaps, challenges and solutions","volume":"34","author":"Pereg","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","article-title":"Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero","volume":"2","author":"Aviles","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","article-title":"Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero","volume":"107","author":"Hahn","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0045","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(79)92878-2","article-title":"Does doxorubicin cross the placenta?","volume":"2","author":"Roboz","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(83)91614-8","article-title":"Transplacental passage of doxorubicin","volume":"1","author":"D'Incalci","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0055","first-page":"773","article-title":"Doxorubicin in pregnancy: possible transplacental passage","volume":"67","author":"Karp","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0060","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.252.18.2607","article-title":"Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report","volume":"252","author":"Murray","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/030089169207800513","article-title":"Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report","volume":"78","author":"Barni","year":"1992","journal-title":"Tumori"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","article-title":"Anthracyclines during pregnancy: embryo\u2013fetal outcome in 160 patients","volume":"15","author":"Germann","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0075","doi-asserted-by":"crossref","unstructured":"Van Calsteren K., Verbesselt R., Van Bree R., Heyns L., de Bruijn E., de Hoon J. et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci. doi:10.1177\/1933719110379650.","DOI":"10.1177\/1933719110379650"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijgo.2006.01.005","article-title":"Efficacy and safety of cordocentesis for prenatal diagnosis","volume":"93","author":"Liao","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1933719108324890","article-title":"Feasibility of ultrasound-guided percutaneous samplings in the pregnant baboon: a model for studies on transplacental transport","volume":"16","author":"Van Calsteren","year":"2009","journal-title":"Reprod Sci"},{"issue":"Suppl A","key":"10.1016\/j.ygyno.2010.08.019_bb0090","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.placenta.2006.11.002","article-title":"Animal models of human placentation\u2014a review","volume":"28","author":"Carter","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1203\/00006450-199807000-00008","article-title":"Placental transfer and fetal metabolism of zidovudine in the baboon","volume":"44","author":"Garland","year":"1998","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0684.2009.00365.x","article-title":"Sonographic biometrical normograms and estimation of fetal weight in the baboon (Papio anubis)","volume":"38","author":"Van Calsteren","year":"2009","journal-title":"J Med Primatol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S1470-2045(05)70424-1","article-title":"Selection of adjuvant chemotherapy for treatment of node-positive breast cancer","volume":"6","author":"Trudeau","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3816\/CLM.2009.n.034","article-title":"Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial","volume":"9","author":"Iannitto","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0115","series-title":"Embryology of the baboon","first-page":"22","author":"Hendrickx","year":"1971"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jchromb.2007.04.024","article-title":"Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS\/MS)","volume":"854","author":"Ekhart","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0125","first-page":"595","article-title":"Transplacental passage of doxorubicin","volume":"18","author":"Grohard","year":"1989","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0130","first-page":"63","article-title":"Transplacental passage of epirubicin","volume":"24","author":"Gaillard","year":"1995","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/bies.20718","article-title":"The blood\u2013CSF barrier explained: when development is not immaturity","volume":"30","author":"Johansson","year":"2008","journal-title":"Bioessays"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0140","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1469-0705.2001.00373.x","article-title":"Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature","volume":"18","author":"Meyer-Wittkopf","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0150","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/annonc\/mdj053","article-title":"Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy","volume":"17","author":"Aviles","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta","volume":"43","author":"Syme","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00262327","article-title":"Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics","volume":"6","author":"Fuks","year":"1981","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0165","series-title":"High Risk Pregnancy: Management Options","year":"2003"},{"key":"10.1016\/j.ygyno.2010.08.019_bb0170","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","article-title":"Designing pregnancy centered medications: drugs which do not cross the human placenta","volume":"27","author":"Gedeon","year":"2006","journal-title":"Placenta"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581000613X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581000613X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T18:09:41Z","timestamp":1559671781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581000613X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S009082581000613X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.08.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}